Inventor
KAMATH KATHRYN
US15 patents
⚠️ This page may combine multiple inventors who share the name “KAMATH KATHRYN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CYTOMX THERAPEUTICS INC
6 patentsUS10118961B2Nov 6, 2018
Modified antibody containing the cleavable peptide with the amino acid sequence TGRGPSWV
CYTOMX THERAPEUTICS INC34 citations96
US9644016B2May 9, 2017
Soluble notch receptor proproteins and methods of use thereof
CYTOMX THERAPEUTICS INC34 citations96
US10059762B2Aug 28, 2018
Anti-EGFR activatable antibodies
CYTOMX THERAPEUTICS INC42 citations95
US8993266B2Mar 31, 2015
Proproteins activatable interferon alpha
CYTOMX THERAPEUTICS INC28 citations94
US10513549B2Dec 24, 2019
Cleavage-activatable interferon-alpha proprotein
CYTOMX THERAPEUTICS INC14 citations93
US10875913B2Dec 29, 2020
Methods of treatment using activatable anti-EGFR antibodies
CYTOMX THERAPEUTICS INC21 citations92
UNIV CALIFORNIA
4 patentsUS10077300B2Sep 18, 2018
Activatable binding polypeptides and methods of identification and use thereof
UNIV CALIFORNIA42 citations97
US9169321B2Oct 27, 2015
Activatable binding polypeptides and methods of identification and use thereof
UNIV CALIFORNIA62 citations97
US11028162B2Jun 8, 2021
Methods for manufacturing activatable binding polypeptides comprising matrix metalloprotease cleavable moieties
UNIV CALIFORNIA6 citations83
US12209120B2Jan 28, 2025
Activatable anti-VEGF scFv
UNIV CALIFORNIA0 citations62
STAGLIANO NANCY E
3 patentsUS8563269B2Oct 22, 2013
Modified antibody compositions, methods of making and using thereof
STAGLIANO NANCY E119 citations97
US8513390B2Aug 20, 2013
Modified antibody compositions, methods of making and using thereof
STAGLIANO NANCY E111 citations97
US8399219B2Mar 19, 2013
Protease activatable interferon alpha proprotein
STAGLIANO NANCY E46 citations97